Modulation the expression of natural killer cell activating receptor (NKp44) in the peripheral blood of diffuse large B-cell lymphoma patients and the correlation with …
ES Essa, GAE Tawfeek, SA El Hassanin… - Clinical Immunology, 2018 - Elsevier
NK cell activation is one strategy to improve the immunotherapy of non-Hodgkin's
lymphoma. So, we aimed to investigate expression of Natural killer cell activating receptor
NKp44 in patients with diffuse large B-cell lymphoma (DLBCL) and its correlation with clinic
pathological data. In this study, 30 new cases with DLBCL in addition to 20 healthy control
were involved. All were submitted to full history, clinical examination, histopathology,
Routine laboratory investigations including CBC, LDH, β2microgloubine and bone marrow …
lymphoma. So, we aimed to investigate expression of Natural killer cell activating receptor
NKp44 in patients with diffuse large B-cell lymphoma (DLBCL) and its correlation with clinic
pathological data. In this study, 30 new cases with DLBCL in addition to 20 healthy control
were involved. All were submitted to full history, clinical examination, histopathology,
Routine laboratory investigations including CBC, LDH, β2microgloubine and bone marrow …
以上显示的是最相近的搜索结果。 查看全部搜索结果